Mrowietz U - Search Results

1

Leptin, adiponectin, visfatin and retinol-binding protein-4 - mediators of comorbidities in patients with psoriasis?

Gerdes S, Osadtschy S, Rostami-Yazdi M, Buhles N, Weichenthal M, Mrowietz U. Gerdes S, et al. Among authors: mrowietz u. Exp Dermatol. 2012 Jan;21(1):43-7. doi: 10.1111/j.1600-0625.2011.01402.x. Exp Dermatol. 2012. PMID: 22151390

2

Significant reduction of human monocyte chemotactic response to monocyte-chemotactic protein 1 in patients with primary and metastatic malignant melanoma.

Müller R, Zheng M, Mrowietz U. Müller R, et al. Among authors: mrowietz u. Exp Dermatol. 1997 Apr;6(2):81-6. doi: 10.1111/j.1600-0625.1997.tb00151.x. Exp Dermatol. 1997. PMID: 9209889

3

Advances in systemic therapy for psoriasis.

Mrowietz U. Mrowietz U. Clin Exp Dermatol. 2001 Jun;26(4):362-7. doi: 10.1046/j.1365-2230.2001.00835.x. Clin Exp Dermatol. 2001. PMID: 11422190 Review.

4

Psoriasis scales contain C5a as the predominant chemotaxin for monocyte-derived dendritic cells.

Mrowietz U, Koch WA, Zhu K, Wiedow O, Bartels J, Christophers E, Schröder JM. Mrowietz U, et al. Exp Dermatol. 2001 Aug;10(4):238-45. doi: 10.1034/j.1600-0625.2001.100403.x. Exp Dermatol. 2001. PMID: 11493312

5

Expression of dipeptidyl-peptidase IV (CD26) on CD8+ T cells is significantly decreased in patients with psoriasis vulgaris and atopic dermatitis.

Bock O, Kreiselmeyer I, Mrowietz U. Bock O, et al. Among authors: mrowietz u. Exp Dermatol. 2001 Dec;10(6):414-9. doi: 10.1034/j.1600-0625.2001.100604.x. Exp Dermatol. 2001. PMID: 11737260

6

Treatment targeted to cell surface epitopes.

Mrowietz U. Mrowietz U. Clin Exp Dermatol. 2002 Oct;27(7):591-6. doi: 10.1046/j.1365-2230.2002.01171.x. Clin Exp Dermatol. 2002. PMID: 12464155 Review.

7

[Classical topical therapy of psoriasis].

Gerdes S, Mrowietz U. Gerdes S, et al. Among authors: mrowietz u. Hautarzt. 2006 Aug;57(8):666-71. doi: 10.1007/s00105-006-1186-8. Hautarzt. 2006. PMID: 16841204 Review. German.

8

Follicular rash during therapy with erlotinib (Tarceva).

Gerdes S, Mrowietz U. Gerdes S, et al. Among authors: mrowietz u. J Dtsch Dermatol Ges. 2006 Oct;4(10):855-7. doi: 10.1111/j.1610-0387.2006.06088.x. J Dtsch Dermatol Ges. 2006. PMID: 17010175 English, German.

9

Dimethylfumarate inhibits nuclear binding of nuclear factor kappaB but not of nuclear factor of activated T cells and CCAAT/enhancer binding protein beta in activated human T cells.

Gerdes S, Shakery K, Mrowietz U. Gerdes S, et al. Among authors: mrowietz u. Br J Dermatol. 2007 May;156(5):838-42. doi: 10.1111/j.1365-2133.2007.07779.x. Epub 2007 Mar 23. Br J Dermatol. 2007. PMID: 17381463

10

Detection of metabolites of fumaric acid esters in human urine: implications for their mode of action.

Rostami-Yazdi M, Clement B, Schmidt TJ, Schinor D, Mrowietz U. Rostami-Yazdi M, et al. Among authors: mrowietz u. J Invest Dermatol. 2009 Jan;129(1):231-4. doi: 10.1038/jid.2008.197. Epub 2008 Aug 14. J Invest Dermatol. 2009. PMID: 18704112 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

409 results

Search Page